C12Y 504/02007
Phosphopentomutase
Official title: Phosphopentomutase (5.4.2.7)
C12Y504/02007 (Phosphopentomutase) appears on 6 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 10
- Assignees
- 7
- Inventors
- 42
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 2 | 1 |
| 2026 | 2 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Engineered phosphopentomutase variant enzymes30 Jun 2026US 12,668,789 B2Codexis, Inc.
- Compositions and uses thereof27 Jan 2026US 12,533,392 B2SkinBio Therapeutics PLC
- Engineered phosphopentomutase variant enzymes23 Sep 2025US 12,421,509 B2Codexis, Inc.
- Escherichia coli-based recombinant strain, construction method therefor and use thereof5 Aug 2025US 12,378,583 B2Inner Mongolia Eppen Biotech Co., Ltd.
- Engineered phosphopentomutase variant enzymes24 Oct 2023US 11,795,445 B2Codexis, Inc.
- Compositions and uses thereof16 Jul 2026US 2026/0199428 A1Skinbiotherapeutics PLC
- Engineered microorganisms with enhanced protein expression and secretion23 Apr 2026US 2026/0109937 A1North Carolina State University
- Engineered phosphopentomutase variant enzymes8 Jan 2026US 2026/0009012 A1Codexis, Inc.
- C-nucleoside monophosphate synthesis27 Feb 2025US 2025/0066828 A1Enginzyme AB
- Engineered phosphopentomutase variant enzymes22 Feb 2024US 2024/0060064 A1Codexis, Inc.
Most cited
By later US patents